Clinical Trial

G-Pola-ZLP in Diffuse Large B-Cell Lymphoma

Name: G-Pola-ZLP in Diffuse Large B-Cell Lymphoma — clinical trial record (NCT06665217)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The goal of this phase 2 trial is to test the safety and efficacy of G-Pola-ZLP as induction therapy in patients with DLBCL.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-10-28.

Trial Details

NCT Number	NCT06665217
Lead Sponsor	Navy General Hospital, Beijing
Conditions	Diffuse Large B-Cell Lymphoma
Enrollment	80 participants
Start Date	2025-09-24
Primary Completion	2029-01 (estimated)
Study Completion	2030-01 (estimated)
Updated on ClinicalTrials.gov	2025-08-14